ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Consolidated Q2 swung to a ₹50 Cr loss from prior-year profit as EBITDA fell to ₹381 Cr from ₹537 Cr on weak soda ash pricing, UK gas costs and the Kenya suspension. Standalone EBITDA rose 22%.
Q2FY27 consolidated revenue ₹4,177 Cr (+8% YoY), EBITDA ₹381 Cr (-29%), PAT loss ₹(50) Cr. H1 revenue ₹8,432 Cr (+11%). Strategy: pivot toward stable, application-led LIFE businesses.
Tata Chemicals reports Q1FY27 consolidated revenue growth of 14% YoY. Management is restructuring reporting into Living, Industrial, and Farm Essentials to focus on non-cyclical, sustainability-led products.
Tata Chemicals delivers resilient growth despite industrial headwinds. Global soda ash pricing remains pressured by Chinese oversupply and Middle East geopolitical shipping costs, while India and agri-segments show margin resilience.
Tata Chemicals reported Q1FY27 consolidated revenue of ₹4,255 Cr with EBITDA of ₹555 Cr. Strategy focuses on LIFE segments (Living, Industrial, Farm Essentials) with significant capacity expansions underway.
Tata Chemicals Q4 FY26 revenue at ₹3,438cr (down 2%); EBITDA at ₹274cr. Significant ₹1,837cr impairment in US operations. Management focused on non-soda ash revenue and supply chain agility amidst Middle East conflict.
Tata Chemicals faces a challenging Q4 FY26 with a massive ₹1,837 crore impairment in the US and margin pressure due to global soda ash overcapacity and pricing corrections.
Tata Chemicals reports Q4FY26 revenue of ₹3,438 Cr and PAT loss of ₹279 Cr, impacted by lower soda ash realizations and a major ₹1,837 Cr US impairment.